Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the sole curative option for patients with myelofibrosis (MF), yet the choice of optimal conditioning regimen continues to be debated. Despite the employment of both reduced-intensity (RIC) and myeloablative (MAC) regimens, concerns regarding relapse and toxicity persist
Treosulfan-based double-alkylator conditioning in myelofibrosis: An Italian retrospective multicenter analysis
Pitino, AnnalisaCo-primo
;Tripepi, Giovanni;D'Arrigo, Graziella;Gori, Mercedes;
2026
Abstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the sole curative option for patients with myelofibrosis (MF), yet the choice of optimal conditioning regimen continues to be debated. Despite the employment of both reduced-intensity (RIC) and myeloablative (MAC) regimens, concerns regarding relapse and toxicity persistFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s41409-025-02791-z (1).pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
426.23 kB
Formato
Adobe PDF
|
426.23 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
